Anne Wojcicki is co-founder and serves as CEO and board member of 23andMe. She is also president and chair of the Anne Wojcicki Foundation. Before founding the firm in 2006, she spent 10 years investing in health care, mostly in biotechnology companies. She is also a general partner at Covalence Life Sciences Partners. Before joining Covalence, she was a senior research analyst at Amerindo Investment Advisors. Prior to that, Ms. Wojcicki worked at Andor Capital Management as a health care analyst, Ardsley Partners as a health care analyst and Investor AB as a senior health care analyst. Ms. Wojcicki also worked at the National Institutes of Health as a research fellow in oncology and hematology. She also worked at the Weizmann Institute as a Biochemistry Fellow and at Yale University as a Research Fellow in the Department of Biochemistry. Ms. Wojcicki received her bachelor's degree in biology from Yale University in 1996.